Ashley Marie Nelson, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hematopoietic Stem Cell Transplantation | 17 | 2024 | 5672 | 1.680 |
Why?
|
Quality of Life | 26 | 2024 | 13347 | 0.960 |
Why?
|
Fatigue | 7 | 2022 | 1550 | 0.650 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 | 2022 | 687 | 0.650 |
Why?
|
Pelvic Exenteration | 1 | 2018 | 21 | 0.630 |
Why?
|
Interleukin-10 | 1 | 2023 | 1172 | 0.580 |
Why?
|
Hematologic Neoplasms | 8 | 2024 | 1896 | 0.570 |
Why?
|
Anxiety | 10 | 2022 | 4570 | 0.570 |
Why?
|
Depression | 14 | 2024 | 8132 | 0.570 |
Why?
|
Adaptation, Psychological | 9 | 2024 | 2629 | 0.470 |
Why?
|
Graft vs Host Disease | 2 | 2024 | 3028 | 0.470 |
Why?
|
Palliative Care | 5 | 2021 | 3592 | 0.450 |
Why?
|
Genital Neoplasms, Female | 1 | 2018 | 532 | 0.420 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2022 | 3612 | 0.390 |
Why?
|
Caregivers | 7 | 2024 | 2241 | 0.370 |
Why?
|
Androgen Antagonists | 2 | 2017 | 1409 | 0.360 |
Why?
|
Thrombectomy | 2 | 2024 | 702 | 0.320 |
Why?
|
Sleep Initiation and Maintenance Disorders | 3 | 2022 | 1080 | 0.270 |
Why?
|
Vertebrobasilar Insufficiency | 2 | 2024 | 113 | 0.270 |
Why?
|
Neoplasms | 9 | 2024 | 22131 | 0.260 |
Why?
|
Terminal Care | 3 | 2021 | 1755 | 0.240 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2022 | 9277 | 0.230 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2022 | 1372 | 0.230 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 4007 | 0.230 |
Why?
|
Sleep | 2 | 2021 | 4758 | 0.220 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2024 | 138 | 0.210 |
Why?
|
Transplantation Conditioning | 2 | 2017 | 1590 | 0.160 |
Why?
|
Middle Aged | 27 | 2024 | 220584 | 0.160 |
Why?
|
Humans | 46 | 2024 | 760617 | 0.150 |
Why?
|
Intracranial Hemorrhages | 1 | 2024 | 809 | 0.150 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2022 | 701 | 0.150 |
Why?
|
Models, Biological | 1 | 2014 | 9461 | 0.150 |
Why?
|
Neurotoxicity Syndromes | 1 | 2022 | 301 | 0.150 |
Why?
|
Transplantation, Homologous | 4 | 2024 | 4804 | 0.150 |
Why?
|
Prostatic Neoplasms | 2 | 2017 | 11106 | 0.140 |
Why?
|
Loneliness | 1 | 2019 | 203 | 0.140 |
Why?
|
Self Efficacy | 1 | 2020 | 636 | 0.130 |
Why?
|
Antiemetics | 1 | 2018 | 186 | 0.130 |
Why?
|
Aged | 17 | 2024 | 169042 | 0.130 |
Why?
|
Male | 25 | 2024 | 360358 | 0.130 |
Why?
|
Female | 26 | 2024 | 392148 | 0.120 |
Why?
|
Pilot Projects | 3 | 2024 | 8618 | 0.120 |
Why?
|
Social Perception | 1 | 2019 | 431 | 0.120 |
Why?
|
Nausea | 1 | 2018 | 679 | 0.120 |
Why?
|
Hospice Care | 1 | 2021 | 677 | 0.120 |
Why?
|
Survivors | 2 | 2024 | 2372 | 0.120 |
Why?
|
Vomiting | 1 | 2018 | 651 | 0.120 |
Why?
|
Immunotherapy, Adoptive | 2 | 2022 | 1467 | 0.120 |
Why?
|
Actigraphy | 1 | 2017 | 521 | 0.110 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2017 | 361 | 0.110 |
Why?
|
Social Support | 2 | 2022 | 2174 | 0.110 |
Why?
|
Postoperative Period | 1 | 2018 | 1813 | 0.110 |
Why?
|
Interleukin-6 | 1 | 2023 | 3206 | 0.110 |
Why?
|
Transplantation, Autologous | 1 | 2017 | 2112 | 0.100 |
Why?
|
Social Stigma | 1 | 2019 | 769 | 0.100 |
Why?
|
Stem Cell Transplantation | 1 | 2021 | 1600 | 0.100 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 1639 | 0.100 |
Why?
|
Qualitative Research | 2 | 2022 | 3016 | 0.100 |
Why?
|
Fear | 1 | 2020 | 1477 | 0.090 |
Why?
|
Registries | 2 | 2024 | 8207 | 0.090 |
Why?
|
Restless Legs Syndrome | 1 | 2014 | 233 | 0.090 |
Why?
|
Interviews as Topic | 1 | 2018 | 2697 | 0.090 |
Why?
|
Mouth Neoplasms | 1 | 2015 | 596 | 0.090 |
Why?
|
Spirituality | 1 | 2014 | 425 | 0.090 |
Why?
|
Adult | 15 | 2022 | 220969 | 0.090 |
Why?
|
Needs Assessment | 1 | 2015 | 1139 | 0.080 |
Why?
|
Family | 1 | 2020 | 3193 | 0.080 |
Why?
|
Cognition | 3 | 2022 | 6987 | 0.080 |
Why?
|
Cytokines | 1 | 2023 | 7373 | 0.080 |
Why?
|
Health Services Needs and Demand | 1 | 2015 | 1400 | 0.070 |
Why?
|
Sexual Behavior | 1 | 2017 | 2187 | 0.070 |
Why?
|
Self Report | 1 | 2017 | 3723 | 0.070 |
Why?
|
Treatment Outcome | 6 | 2024 | 64568 | 0.060 |
Why?
|
Cognition Disorders | 1 | 2019 | 3979 | 0.060 |
Why?
|
Survival Rate | 1 | 2018 | 12719 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2019 | 4488 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2015 | 3451 | 0.050 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 26049 | 0.050 |
Why?
|
Basilar Artery | 1 | 2024 | 205 | 0.050 |
Why?
|
Young Adult | 5 | 2022 | 59179 | 0.050 |
Why?
|
Genetic Variation | 1 | 2018 | 6561 | 0.050 |
Why?
|
Prognosis | 4 | 2024 | 29600 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11736 | 0.050 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2014 | 1875 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 6925 | 0.040 |
Why?
|
Arterial Occlusive Diseases | 1 | 2024 | 748 | 0.040 |
Why?
|
Aged, 80 and over | 5 | 2024 | 58894 | 0.040 |
Why?
|
Inflammation | 1 | 2019 | 10760 | 0.040 |
Why?
|
Translations | 1 | 2019 | 81 | 0.040 |
Why?
|
Pituitary-Adrenal System | 1 | 2022 | 552 | 0.040 |
Why?
|
Factor Analysis, Statistical | 1 | 2019 | 997 | 0.030 |
Why?
|
Death | 1 | 2021 | 674 | 0.030 |
Why?
|
Perception | 1 | 2022 | 1198 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 2 | 2022 | 5672 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2023 | 1411 | 0.030 |
Why?
|
Uncertainty | 1 | 2020 | 752 | 0.030 |
Why?
|
Risk Factors | 3 | 2018 | 74115 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13382 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2024 | 80566 | 0.030 |
Why?
|
Nitriles | 1 | 2018 | 971 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39063 | 0.030 |
Why?
|
Sexual Partners | 1 | 2017 | 800 | 0.030 |
Why?
|
Regression Analysis | 1 | 2020 | 6338 | 0.020 |
Why?
|
Physical Therapy Modalities | 1 | 2014 | 530 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2019 | 1884 | 0.020 |
Why?
|
Communication | 1 | 2024 | 3849 | 0.020 |
Why?
|
Psychometrics | 1 | 2019 | 3060 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6807 | 0.020 |
Why?
|
Pyrazoles | 1 | 2018 | 2008 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14591 | 0.020 |
Why?
|
Internet | 1 | 2019 | 3090 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3194 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 7995 | 0.020 |
Why?
|
Pyrimidines | 1 | 2018 | 3027 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2024 | 10175 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7050 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54360 | 0.020 |
Why?
|
Psychotherapy | 1 | 2014 | 1648 | 0.020 |
Why?
|
Child | 2 | 2022 | 80079 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5332 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8645 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20074 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18381 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22148 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15689 | 0.010 |
Why?
|
Pregnancy | 1 | 2019 | 29868 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15828 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13635 | 0.010 |
Why?
|
Hospitalization | 1 | 2014 | 10704 | 0.010 |
Why?
|